ReviewFundamental research2026
Bioelectric warfare on bone infection: The role of piezoelectric biomaterials in osteomyelitis management.
Review in Fundamental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Piezoelectric materials represent an emerging frontier in osteomyelitis therapy, offering innovative solutions to persistent challenges in bone infection treatment. These materials utilize their inherent electromechanical coupling properties to convert external stimuli, such as ultrasound and mechanical stress, into localized electrical signals. This capability facilitates targeted antibacterial effects through enhanced reactive oxygen species (ROS) generation, promotes endogenous growth factor secretion, and stimulates osteogenic differentiation-all while supporting bone regeneration. Recent advances in nano-piezoelectric systems, including hybrid organic-inorganic composites, demonstrate significant potential for addressing the complex pathophysiology of osteomyelitis, including biofilm formation, avascular necrosis, and impaired osseointegration. This review examines material classifications, antibacterial mechanisms, and regenerative applications of piezoelectric technology in bone infection management, highlighting their role in combined antibacterial-osteogenic strategies. With compelling preclinical outcomes, these materials pave the way for next-generation therapies that simultaneously eradicate infection and promote bone repair. Future research should prioritize optimizing biodegradability, enhancing piezoelectric efficiency in biological environments, and integrating these materials with conventional debridement and antibiotic therapies for clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.